Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia – a FILO study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Leukemia

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1038/s41375-024-02335-2

License

CC-BY

Other Formats

PDF